Patents by Inventor Elisavet Makou

Elisavet Makou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEINS WITH DIAGNOSTIC AND THERAPEUTIC USES
    Publication number: 20220009974
    Abstract: A method of treating one or more medical complications associated with aberrant complement regulatory activity in a subject includes the steps of: providing a pharmaceutical composition comprising a recombinant protein capable of binding to complement factor H (CFH) and inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH; and administering to a subject an effective amount of the pharmaceutical composition.
    Type: Application
    Filed: September 24, 2021
    Publication date: January 13, 2022
    Inventors: Paul Barlow, Andrew Herbert, Elisavet Makou
  • PROTEINS WITH DIAGNOSTIC AND THERAPEUTIC USES
    Publication number: 20210017239
    Abstract: A recombinant protein for use in the treatment of one or more medical complications associated with aberrant complement regulatory activity in a subject, the recombinant protein capable of binding to complement factor H (CFH) and inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH.
    Type: Application
    Filed: August 17, 2020
    Publication date: January 21, 2021
    Inventors: Paul Barlow, Andrew Herbert, Elisavet Makou
  • Proteins with diagnostic and therapeutic uses
    Patent number: 10774116
    Abstract: The present invention provides a recombinant protein capable of binding to complement factor H (CFH), and thereby inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH. Methods and medical devices for using utilising the same are also described.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: September 15, 2020
    Assignee: The University Court of the University of Edinburgh
    Inventors: Paul Barlow, Andrew Herbert, Elisavet Makou
  • PROTEINS WITH DIAGNOSTIC AND THERAPEUTIC USES
    Publication number: 20190100563
    Abstract: The present invention provides a recombinant protein capable of binding to complement factor H (CFH), and thereby inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH. Methods and medical devices for using utilising the same are also described.
    Type: Application
    Filed: July 6, 2018
    Publication date: April 4, 2019
    Inventors: Paul Barlow, Andrew Herbert, Elisavet Makou
  • Proteins with diagnostic and therapeutic uses
    Patent number: 10035827
    Abstract: The present invention provides a recombinant protein capable of binding to complement factor H (CFH), and thereby inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH. Methods and medical devices for using utilizing the same are also described.
    Type: Grant
    Filed: October 13, 2014
    Date of Patent: July 31, 2018
    Assignee: The University Court of the University of Edinburgh
    Inventors: Paul Barlow, Andrew Herbert, Elisavet Makou
  • PROTEINS WITH DIAGNOSTIC AND THERAPEUTIC USES
    Publication number: 20160237125
    Abstract: The present invention provides a recombinant protein capable of binding to complement factor H (CFH), and thereby inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH. Methods and medical devices for using utilising the same are also described.
    Type: Application
    Filed: October 13, 2014
    Publication date: August 18, 2016
    Inventors: Paul Barlow, Andrew Herbert, Elisavet Makou